News Articles on {?keyword?} | ABS-CBN News

Regeneron says COVID antibody treatment may be less effective vs Omicron

Agence France-Presse
Posted at Dec 01 12:32 PM

US biotech firm Regeneron said its synthetic antibody treatment for COVID-19 may be less effective against Omicron, and it plans to conduct tests to determine by how much. Read more »

WHO backs Regeneron COVID-19 drug cocktail

Reuters
Posted at Sep 24 07:50 AM

The treatment has been granted US emergency use authorization, having gained attention when used to treat Trump's COVID-19 illness last year. Read more »

Japan becomes first country to approve Ronapreve COVID-19 treatment

Agence France-Presse
Posted at Jul 20 07:00 PM

Swiss pharmaceutical giant Roche said Tuesday that Japan had become the first country to fully approve its Ronapreve antibody treatment for patients with mild to moderate COVID-19. Read more »

Regeneron's antibody therapy cuts deaths among some hospitalized COVID-19 patients - study

Alistair Smout, Reuters
Posted at Jun 16 08:42 PM

LONDON - A COVID-19 antibody cocktail developed by Regeneron Pharmaceuticals Inc and Roche reduced deaths in hospitalized patients whose own immune systems had failed to produce a response, a large British study found on Wednesday. Read more »

COVID SCIENCE: Physical inactivity tied to higher COVID-19 risk

Nancy Lapid, Reuters
Updated as of Apr 20 09:03 AM

Patients with COVID-19 who have been consistently physically inactive have a significantly higher risk of severe outcomes than patients who were getting at least some exercise or regularly met physical activity guidelines prior to the illness, researchers found.  Read more »

Regeneron says antibody injection drastically reduced COVID infection

Agence France-Presse
Posted at Apr 13 04:49 AM

No one who received the treatment was hospitalized or had to go to an emergency room for COVID-19, while four who received the placebo did. Read more »

Regeneron's COVID-19 cocktail helps prevent symptomatic disease - study

John Miller, Reuters
Posted at Apr 12 08:27 PM

ZURICH - Regeneron will seek US approval for its COVID-19 antibody cocktail as a preventative treatment after a trial showed it helped reduce the risk of symptomatic infections in households where someone else is ill, the US drugmaker said on Monday. Read more »

US approves Regeneron antibody treatment given to Trump

Agence France-Presse
Updated as of Nov 22 01:07 PM

A COVID-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.   Read more »

Regeneron says its COVID-19 antibody treatment cut medical visits in trial

Michael Erman, Reuters
Posted at Oct 29 06:40 AM

Regeneron Pharmaceuticals Inc said on Wednesday its coronavirus antibody cocktail - the experimental treatment that US President Donald Trump received - significantly reduced medical visits in a trial of nearly 800 patients with mild-to-moderate COVID-19.   Read more »

The race for an antibody against the coronavirus

Apoorva Mandavilli, The New York Times
Updated as of Oct 14 12:17 PM

Even as vaccines are hailed as our best hope against the coronavirus, dozens of scientific groups are working on an alternate defense: monoclonal antibodies. These therapies shot to prominence just this month after President Donald Trump got an infusion of an antibody cocktail made by Regeneron and credited it for his apparent recovery, even calling it a “cure.” Read more »

Regeneron antibodies in demand after Trump treatment, doctors seek more data

Deena Beasley, Reuters
Posted at Oct 08 12:33 PM

Regeneron Pharmaceuticals Inc has submitted a request to the US Food and Drug Administration for an emergency use authorization for its antibody combination. Read more »

What you need to know about Regeneron's COVID-19 treatment

Issam Ahmed, Agence France-Presse
Posted at Oct 04 08:03 AM

President Donald Trump was treated Friday for COVID-19 with a high-dose of the experimental antibody drug developed by the US biotech firm Regeneron.    Read more »

The coronavirus could dodge some treatments, study suggests

Katherine J. Wu, The New York Times
Posted at Jul 29 07:05 AM

In a laboratory in New York City, researchers coaxed a key piece of the coronavirus — its infamous outer “spike” — to mutate so that it became invisible to disease-fighting antibodies, according to a new study that has not yet been published in a scientific journal. Read more »

These scientists raced to find a COVID-19 drug. Then the virus found them.

Katie Thomas, The New York Times
Posted at Jul 10 11:59 AM

Stephanie Giordano, the youngest member of the company’s five-person rapid response team for infectious diseases, helped develop what many consider one of the most promising new treatments for COVID-19, which has now infected more than 12 million people around the world and killed more than 549,000. Read more »

US awards $1.6 billion to Novavax for COVID-19 vaccine

Agence France-Presse
Posted at Jul 08 11:35 AM

The US on Tuesday announced it was providing $1.6 billion in funding for the development and manufacture of a COVID-19 vaccine candidate produced by biotech firm Novavax, the largest amount awarded under Operation Warp Speed. Read more »

US pharmaceutical company begins human testing of COVID-19 antibody cocktail

Deena Beasley, Reuters
Posted at Jun 11 08:10 PM

Regeneron's cocktail - which contains an antibody made by the company and a second isolated from humans who recovered from COVID-19 - is designed so that its two antibodies bind to the coronavirus' spike protein, limiting the ability of viruses to escape. Read more »

Regeneron, Sanofi to treat only 'critical' COVID-19 patients with arthritis drug

Reuters
Updated as of Apr 27 09:35 PM

Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday they would test their arthritis drug, Kevzara, in critically ill COVID-19 patients after the drug showed no benefit for patients with a less severe form of the disease. Read more »

South Korea’s government officials to donate 30 % of their salaries to COVID-19 efforts

Updated as of Mar 31 08:52 AM

Plus, a Nobel laureate predicts the world will recover faster than previously thought, and developments in Japan and the US in finding a cure spark hope. BY JACS T. SAMPAYAN Read more »

US drugmaker says has identified antibodies to treat coronavirus

Saumya Joseph, Reuters
Posted at Mar 24 05:46 PM

Regeneron Pharmaceuticals Inc has said it had identified hundreds of antibodies that could treat or prevent the coronavirus and was preparing to begin clinical trials by early summer, sending the drugmaker's shares up 12 percent. Read more »

Regeneron plans early summer trials for new antibodies against coronavirus

Saumya Joseph, Reuters
Posted at Mar 17 10:40 PM

Regeneron Pharmaceuticals Inc said on Tuesday it had identified hundreds of antibodies that could treat or prevent the coronavirus and was preparing to begin clinical trials by early summer, sending the drugmaker's shares up nearly 12 percent.  Read more »